BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 17653126)

  • 1. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.
    Roncarolo MG; Battaglia M
    Nat Rev Immunol; 2007 Aug; 7(8):585-98. PubMed ID: 17653126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?
    Bayry J; Lacroix-Desmazes S; Dasgupta S; Kazatchkine MD; Kaveri SV
    Nat Rev Immunol; 2008 Jan; 8(1):1p following 86; author reply 1p following 86. PubMed ID: 18049489
    [No Abstract]   [Full Text] [Related]  

  • 3. What does the future hold for cell-based tolerogenic therapy?
    Bluestone JA; Thomson AW; Shevach EM; Weiner HL
    Nat Rev Immunol; 2007 Aug; 7(8):650-4. PubMed ID: 17653127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells.
    Wood KJ; Bushell A; Jones ND
    Immunol Rev; 2011 May; 241(1):119-32. PubMed ID: 21488894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis.
    van Herwijnen MJ; Wieten L; van der Zee R; van Kooten PJ; Wagenaar-Hilbers JP; Hoek A; den Braber I; Anderton SM; Singh M; Meiring HD; van Els CA; van Eden W; Broere F
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14134-9. PubMed ID: 22891339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
    Chen W; Ford MS; Young KJ; Zhang L
    Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of regulatory T Cells in autoimmune orchitis.
    Jacobo P
    Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of regulatory T cells in cellular therapies in autoimmune diseases].
    Boursier G; Siri A; de Boysson H
    Med Sci (Paris); 2012; 28(8-9):757-63. PubMed ID: 22920878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific therapy for autoimmune disease.
    Harrison LC; Hafler DA
    Curr Opin Immunol; 2000 Dec; 12(6):704-11. PubMed ID: 11102776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity.
    Wright GP; Ehrenstein MR; Stauss HJ
    Expert Rev Clin Immunol; 2011 Mar; 7(2):213-25. PubMed ID: 21426259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
    Wolfraim LA
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
    Selck C; Dominguez-Villar M
    Front Immunol; 2021; 12():661875. PubMed ID: 34054826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T
    Raffin C; Vo LT; Bluestone JA
    Nat Rev Immunol; 2020 Mar; 20(3):158-172. PubMed ID: 31811270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Antigen-Specific Tolerance in T Cell Mediated Diseases.
    Passerini L; Gregori S
    Front Immunol; 2020; 11():2194. PubMed ID: 33133064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells: cellular mediators for immunological tolerance.
    Chung CY; Ysebaert D; Berneman ZN; Cools N
    Clin Dev Immunol; 2013; 2013():972865. PubMed ID: 23762100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases.
    Bayry J
    Immunotherapy; 2012 Jan; 4(1):9-12. PubMed ID: 22149994
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases.
    Chen Y; Sun J; Liu H; Yin G; Xie Q
    J Immunol Res; 2019; 2019():5727516. PubMed ID: 32083141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cells.
    Matta B; Jha P; Bora PS; Bora NS
    Am J Pathol; 2008 Nov; 173(5):1440-54. PubMed ID: 18832572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.